Dual-Modality Ultrasound Imaging of SPIONs Distribution via Combined Magnetomotive and Passive Cavitation Imaging
Sensors · 2025
DOI: 10.3390/s25237171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2025. Verfasst von Christian Marinus Huber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Else Kröner-Fresenius Foundation, Section of Experimental Oncology and Nanomedicine (SEON),…. Hauptthemen laut MEDLINE: Magnetic Iron Oxide Nanoparticles, Magnetite Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Julitta and Richard Müller Stiftung.
Abstract (Originalsprache)
Superparamagnetic iron oxide nanoparticles (SPIONs) have shown promise across a wide range of biomedical applications, including targeted drug delivery, magnetic hyperthermia, magnetic resonance imaging, and regenerative medicine. In the context of local tumor therapy (Magnetic Drug Targeting, MDT) SPIONs can be functionalized with chemotherapeutic agents and accumulated at tumor sites using an externally applied magnetic field. To achieve effective drug accumulation and therapeutic efficacy, precise positioning of the accumulation magnet relative to the tumor is essential. To address this need, we propose a dual-modality ultrasound imaging approach combining magnetomotive ultrasound (MMUS) and passive cavitation mapping (PCM). MMUS detects magnetically induced displacements to localize SPIONs embedded in elastic tissue, while PCM monitors cavitation emissions from circulating SPIONs under focused ultrasound exposure. In addition to detection, PCM has the potential to enable feedback-based control of cavitation exposure, allowing cavitation parameters to be kept within a safe regime. The dual imaging modality approach was validated using standard phantoms and a complex carotid bifurcation tumor flow phantom fabricated via 3D printing. Experimental results demonstrate the first coordinated spatiotemporal imaging of MMUS and PCM within the same anatomical model, resolving the key bottleneck of SPIONs monitoring in blood vessels/tissue. This demonstrates the strong potential of complementary MMUS and PCM imaging for monitoring in preclinical and clinical MDT settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, Else Kröner-Fresenius Foundation, Section of Experimental Oncology and Nanomedicine (SEON), Professorship for AI-Controlled Nanomaterials (KINAM), Universitätskl…
- Institute of Microwaves and Photonics (LHFT), Friedrich-Alexander-Universität Erlangen-Nürnberg, 91058 Erlangen, Germany.
- Department of Microsystems Engineering, University of Freiburg, 79110 Freiburg im Breisgau, Germany.
ORCID-Profile: Christian Marinus Huber, Johannes Ringel, Helmut Ermert, Martin Vossiek, Stefan J Rupitsch, Ingrid Ullmann, Stefan Lyer
Förderung
- Deutsche Forschungsgemeinschaft
- Julitta and Richard Müller Stiftung
Zitieren
APA
Huber, C. M., Hageroth, L., Dorsch, N., Ringel, J., Ermert, H., Vossiek, M., Rupitsch, S. J., Ullmann, I., & Lyer, S. (2025). Dual-Modality Ultrasound Imaging of SPIONs Distribution via Combined Magnetomotive and Passive Cavitation Imaging. Sensors. https://doi.org/10.3390/s25237171
Vancouver
Huber CM, Hageroth L, Dorsch N, Ringel J, Ermert H, Vossiek M, et al. Dual-Modality Ultrasound Imaging of SPIONs Distribution via Combined Magnetomotive and Passive Cavitation Imaging. Sensors. 2025. doi:10.3390/s25237171
BibTeX
@article{Huber2025,
author = {Huber, Christian Marinus and Hageroth, Lars and Dorsch, Nicole and Ringel, Johannes and Ermert, Helmut and Vossiek, Martin and Rupitsch, Stefan J and Ullmann, Ingrid and Lyer, Stefan},
title = {Dual-Modality Ultrasound Imaging of SPIONs Distribution via Combined Magnetomotive and Passive Cavitation Imaging},
journal = {Sensors},
year = {2025},
doi = {10.3390/s25237171}
}
EUVIMED